Jennifer Pietenpol

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read More

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More

The grants, which total $830,000, are part of the non-profit organization’s commitment to young scientists, as well as established investigators who are searching for more effective breast cancer therapies. Read More

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. Read More

Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers. Read More

Vanderbilt-Ingram Cancer Center investigators are receiving $1 million in breast cancer research grant funds from Susan G. Komen, the largest nonprofit foundation supporting breast cancer research. Read More

Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read More

Vanderbilt-Ingram Cancer Center researchers have identified six subtypes of an aggressive and difficult-to-treat form of breast cancer. Read More

A gene signature may be useful in predicting outcomes for patients with rhabdomysarcoma, a form of cancer most commonly diagnosed in children. Read More

President George W. Bush has appointed Jennifer A. Pietenpol, director of Vanderbilt-Ingram Cancer Center, to the National Cancer Advisory Board. Pietenpol, the B.F. Byrd Jr. Professor of Oncology at Vanderbilt-Ingram, will serve a six-year term through March 9, 2014. Read More

Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center. Read More